NCT00139620 2018-02-08A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic FunctionAstellas Pharma IncPhase 1 Completed39 enrolled